Coherus Oncology, Inc. · NASDAQ:CHRS
BlackRock, Inc. reported a 5.80% stake in Coherus Oncology, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 5.80% stake in Coherus Oncology, Inc., 8,934,952 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 8,934,952
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.80% | 8,934,952 |
Source
Related
- Coherus Oncology, Inc.
- BlackRock, Inc.
- Coherus Oncology, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Form 4 · Satvat Ali J. · Jun 9, 2026
- Form 4 · Karachun Rita A · Jun 9, 2026
- Form 4 · Newcomer Lee Nisley · Jun 9, 2026
- Form 4 · Ryan Michael Lee · Jun 9, 2026
- Form 4 · O'Donnell-Tormey Jill · Jun 9, 2026